Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000929638-25-000790
Filing Date
2025-02-14
Accepted
2025-02-14 16:26:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 10721
  Complete submission text file 0000929638-25-000790.txt   12436
Mailing Address 140 EAST 45TH STREET 24TH FLOOR NEW YORK NY 10017
Business Address 140 EAST 45TH STREET 24TH FLOOR NEW YORK NY 10017 212-973-1900
DME Capital Management, LP (Filed by) CIK: 0001489933 (see all company filings)

EIN.: 272046123 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Subject) CIK: 0001835022 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-93853 | Film No.: 25629465
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)